박현정 (한양대학교)님 | 한빛사연구자 > 한빛사

한양대학교

최종업데이트 2025.10.14.

Targeted genome editing of ZKSCAN3 mitigates the neurotoxicity caused by mutant HTT (huntingtin) in a Huntington disease animal model and three-dimensional cell culture of Huntington disease
- Autophagy, Oct 10 2025, | https://doi.org/10.1080/15548627.2025.2569965
- 2025-10
- 의약학
- 한빛사논문
SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington’s disease
- npj Regen. Med., Published 19 January 2022 | https://doi.org/10.1038/s41536-021-00198-0
- 2022-01
- 생명과학
- 한빛사논문
Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson’s disease
- J. Neurochem., Volume107, Issue1, October 2008, Pages 141-151 | https://doi.org/10.1111/j.1471-4159.2008.05589.x
- 2008-10
- 의약학
- 상위피인용논문
Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action
- Glia, Volume 57, Issue 1, pages 13-23, 1 January 2009 | DOI: 10.1002/glia.20731
- 2009-01
- 의약학
- 상위피인용논문
Mesenchymal stem cells enhance α-synuclein clearance via M2 microglia polarization in experimental and human parkinsonian disorder.
- Acta Neuropathol., First Online: 06 August 2016 | DOI: 10.1007/s00401-016-1605-6
- 2016-08
- 의약학
- 한빛사논문

연구자 ID

저자논문